Anticoagulation with direct-acting anticoagulants decreases the risk of cardiovascular adverse events in patients with heart failure and atrial fibrillation compared to acenocoumarol

被引：0
|
作者：
Gonzalez Leal, A. [1 ]
Sanchez Vega, J. D. [1 ]
Antonana Ugalde, S. [1 ]
Arteagoitia Bolumburu, A. [1 ]
Alvarez-Garcia, J. [1 ]
Del Prado, S. [1 ]
Cordero, D. [1 ]
Jimenez-Blanco, M. [1 ]
Castillo, M. [1 ]
Gonzalez Ferrer, E. [1 ]
Zamorano, J. L. [1 ]
Alonso Salinas, G. L. [2 ]
机构：
[1] Hosp Ramon & Cajal, Cardiol Dept, Madrid, Spain
[2] Hosp Complex Navarra, Pamplona, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [41] Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications
    Raschi, Emanuel
    Bianchin, Matteo
    Ageno, Walter
    De Ponti, Roberto
    De Ponti, Fabrizio
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2016, 126 (7-8): : 552 - 561
  • [42] Anticoagulation in atrial fibrillation and chronic heart failure: the risk and drug of choice
    Boos, Christopher J.
    Brown, Louise
    CURRENT OPINION IN CARDIOLOGY, 2016, 31 (02) : 229 - 234
  • [43] Use of cardiovascular drugs and risk of incident heart failure in patients with atrial fibrillation
    Wandell, Per
    Carlsson, Axel C.
    Li, Xinjun
    Holzmann, Martin J.
    Sundquist, Jan
    Sundquist, Kristina
    JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (08): : 1396 - 1405
  • [44] Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation
    Saeed, Omar
    Zhang, Shuaiqi
    Patel, Snehal R.
    Jorde, Ulrich P.
    Garcia, Mario J.
    Bulcha, Nurilign
    Gupta, Tanush
    Xian, Ying
    Matsouaka, Roland
    Shah, Shreyansh
    Smith, Eric E.
    Schwamm, Lee H.
    Fonarow, Gregg C.
    JOURNAL OF CARDIAC FAILURE, 2021, 27 (08) : 857 - 864
  • [45] Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation A Systematic Review
    Wan, Yi
    Heneghan, Carl
    Perera, Rafael
    Roberts, Nia
    Hollowell, Jennifer
    Glasziou, Paul
    Bankhead, Clare
    Xu, Yongyong
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2008, 1 (02): : 84 - 91
  • [46] microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
    de los Reyes-Garcia, Ascension M.
    Zapata-Martinez, Laura
    Aguila, Sonia
    Lozano, Maria L.
    Martinez, Constantino
    Gonzalez-Conejero, Rocio
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [47] ALLOPURINOL DECREASES THE INCIDENCE OF ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS
    Hernandez, Fernando Enrique
    Tamariz, Leonardo
    Hare, Joshua
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E409 - E409
  • [48] Real world persistence with direct oral anticoagulants in anticoagulation naive patients with atrial fibrillation
    Denas, G.
    Costa, G.
    Ferroni, E.
    Gennaro, N.
    Fedeli, U.
    Corti, M. C.
    Zoppellaro, G.
    Jose, S. Padayattil
    Pengo, V.
    EUROPEAN HEART JOURNAL, 2019, 40 : 165 - 165
  • [49] Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
    Vedovati, Maria Cristina
    Agnelli, Giancarlo
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (08):
  • [50] Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
    Yoo, Seo Yeon
    Kim, Eunju
    Nam, Gi-Byoung
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Choi, Jonggi
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (03): : 555 - 566
12345